Mithra Pharmaceuticals SA
0.2180
26-April-24 09:18:45
15 minutes delayed
Stocks
-0.0035
-1.58%
Today's range
0.2180 - 0.2205
ISIN
BE0974283153
Source
Cboe
-
03 May 2024 10:30:00 By Nasdaq GlobeNewswire
-
Mithra reports full year 2023 financial results
08 Mar 2024 00:00:00 By Nasdaq GlobeNewswire
-
Mithra announces changes to its executive management
05 Mar 2024 00:01:00 By Nasdaq GlobeNewswire
-
Mithra initiates monetization process, receives bridge loan from existing lenders
05 Mar 2024 00:00:00 By Nasdaq GlobeNewswire
-
29 Feb 2024 04:42:16 By Nasdaq GlobeNewswire
-
Mithra sells shares in Mayne Pharma
15 Feb 2024 11:23:05 By Nasdaq GlobeNewswire
-
Mithra updates on cash position
06 Feb 2024 00:00:00 By Nasdaq GlobeNewswire
-
Mithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA® in Israel
21 Dec 2023 10:45:00 By Nasdaq GlobeNewswire
-
Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients
20 Dec 2023 10:45:00 By Nasdaq GlobeNewswire
-
Mithra Receives Positive DSMB Opinion on DONESTA® European Phase 3 Trial
18 Dec 2023 00:00:00 By Nasdaq GlobeNewswire
-
Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China
04 Dec 2023 00:00:00 By Nasdaq GlobeNewswire
-
30 Nov 2023 00:00:00 By Nasdaq GlobeNewswire
-
28 Nov 2023 10:45:00 By Nasdaq GlobeNewswire
-
Mithra’s NEXTSTELLIS® granted additional patent in the United States
07 Nov 2023 00:00:00 By Nasdaq GlobeNewswire
-
Mithra releases invitation to its extraordinary securities holders’ meeting
06 Nov 2023 11:52:53 By Nasdaq GlobeNewswire
-
Mithra and Searchlight Pharma sign DONESTA® licensing agreement for Canada
26 Oct 2023 00:00:00 By Nasdaq GlobeNewswire
-
23 Oct 2023 00:00:00 By Nasdaq GlobeNewswire
-
17 Oct 2023 00:00:00 By Nasdaq GlobeNewswire
-
11 Oct 2023 00:15:00 By Nasdaq GlobeNewswire
-
Mithra announces update to the agenda of its upcoming special general shareholders’ meeting
11 Oct 2023 00:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >